Skip to main content
. 2024 Feb 23;6:1284878. doi: 10.3389/fspor.2024.1284878

Table 2.

Steps and intensity of habitual physical activity over time in the ETI group and the non-ETI group from baseline to follow-up.

ETI group (n = 21) non-ETI group (n = 6) Between-group comparison p-value Within-group comparison p-value
Baseline Follow-up Baseline Follow-up Baseline Follow-up ETI group non-ETI group
Steps (number/day) 8,798 ± 3,176 (7,352/10,243) 10,997 ± 3,468 (9,354/12,600)* 11,530 ± 3,636 (8,490/14,569) 11,164 ± 3,724 (8,716/14,908) 0 . 042 0.785 0.019 0.893
Total change (steps/day) 2,131.3 ± 3,268.7 (556.4/3,707.3) −305.7 ± 2,628.1 (−2,351.7, 1,740.3)    
Annual change in steps/day 414.0 ± 699.5 (76.9/751.2) −86.8 ± 401.0 (457.6/284.1) 0.060      
Sedentary-to-light intensity HPA (<3 METs), in min/day 1,218.5 ± 133.9 (1,149.6/1,287.4) 1,170.6 ± 117.6 (1,115.7/1,287.4) 1,254.1 ± 197.4 (763.8/1,744.4) 1,103.0 ± 136.8 (885.4/1,320.6) 0.491 0.278 0.543 0.416
Moderate-to-vigorous intensity HPA (3–5.9 METs), in min/day 106.3 ± 90.6 (60.2/140.3) 112.1 ± 74.1 (74.4/143.8) 123.0 ± 101.0 (17.0/229.0) 92.2 ± 36.8 (46.5/137.9) 0.466 0.946 0.352 0.207
Vigorous HPA (≥6 METs), in min/day 16.7 ± 18.7 (6.5/27.7) 13.6 ± 18.6 (8.2, 22.3) 19.6 ± 20.0 (2.9/36.4) 18.3 ± 18.3 (−0.9/7.6) 0.767 0.407 0.363 0.465

Values are mean ± standard deviation (95% confidence interval).

Baseline, assessment of habitual physical activity and clinical parameters; Follow-up, assessment of habitual physical activity and clinical parameters. Statistical testing: Kruskal–Wallis test (between groups); Mann–Whitney U-test (within groups); Friedman two-way analysis of variance by ranks test to compare the changes over time; Chi-Quadrat (2), χ² (post hoc tests).

HPA, habitual physical activity; ETI, elexacaftor/tezacaftor/ivacaftor; METS, metabolic equivalents.

Bold type indicates a significant result.